Covid-19 antibody therapies show promising early results in separate trials

Days after Eli Lilly and Company said it would stop a trial of its Covid-19 antibody therapy in hospitalized patients because it was not effective, the company on Wednesday published promising interim results from a trial involving patients with mild and moderate Covid-19.